BUDGET IMPACT ANALYSIS OF ECULIZUMAB BIOSIMILAR FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FROM PUBLIC HOSPITAL PERSPECTIVE IN 2023

被引：0
|
作者：
Robin, P. [1 ]
De Coucy, A. [2 ]
Hadjadj, C. [1 ]
Petiteau, Moreau F. [3 ]
机构：
[1] Univ Hosp Bordeaux, Pessac, Nouvelle Aquita, France
[2] Univ Hosp Bordeaux, GCS UniHA, Pessac, Nouvelle Aquita, France
[3] Univ Hosp Bordeaux, F-33 Pessac, France
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P42
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [1] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [2] Cost-Utility Analysis of Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria from the Perspective of the Brazilian Public Health System
    Cruz, Daniela Souza
    Santos, Marisa da Silva
    Santos, Braulio
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 26 : 113 - 125
  • [3] Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab
    Roeth, Alexander
    Duehrsen, Ulrich
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (06) : 473 - 479
  • [4] Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study
    Loschi, Michael
    Porcher, Raphael
    Barraco, Fiorenza
    Terriou, Louis
    Mohty, Mohamad
    de Guibert, Sophie
    Mahe, Beatrice
    Lemal, Richard
    Dumas, Pierre-Yves
    Etienne, Gabriel
    Jardin, Fabrice
    Royer, Bruno
    Bordessoule, Dominique
    Rohrlich, Pierre Simon
    Fornecker, Luc Mathieu
    Salanoubat, Celia
    Maury, Sebastien
    Cahn, Jean-Yves
    Vincent, Laure
    Sene, Thomas
    Rigaudeau, Sophie
    Nguyen, Stephanie
    Lepretre, Anne-Claire
    Mary, Jean-Yves
    Corront, Bernadette
    Socie, Gerard
    de Latour, Regis Peffault
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (04) : 366 - 370
  • [5] ORPHAN DRUGS: ECULIZUMAB IN THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Fernandez-Jurado, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 4 - 4
  • [6] Evaluation of the use of eculizumab for treatment of paroxysmal nocturnal hemoglobinuria
    Maria de Andres, Ana
    Sola, Nuria
    Creus, Natalia
    Codina, Carles
    Ribas, Josep
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 299 - 300
  • [7] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
    Rodriguez-Garcia, Juan
    Fernandez-Santos, Rafael
    Antonio Garcia-Erce, Jose
    MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
  • [8] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
  • [9] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
    Fassett, Michael J.
    Lopez, Adrian L. Hernandez
    CASE REPORTS IN WOMENS HEALTH, 2021, 30
  • [10] Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatment
    Arcavi, Miriam
    Ceballo, Fernanda
    Caracciolo, Maria Beatriz
    Lazarowski, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 335 - 340
12345